Skip to main content
. 2023 Jun 15;13:9736. doi: 10.1038/s41598-023-36578-3

Table 1.

Characteristics of blind participants.

# Group Age Sex Blindness cause Blindness onset BDI Residual vision SBSOD score
1 EB 50 M ROP  ~ Birth 1 89.52
2 EB 36 F Glaucoma 6 0.83 LP 89.52
3 EB 30 M Leber hereditary optic neuropathy Birth 1 62.86
4 EB 31 M Microphthalmia + glaucoma Birth 1 LP in one eye 61.90
5 EB 29 M ROP  ~ Birth 1 74.29
6 EB 42 M Retinoblastoma 3 0.93 83.81
7 EB 32 M ROP  ~ Birth 1 56.19
8 EB 33 M Septo-optic dysplasia Birth 1 79.05
9 EB 39 F ROP  ~ Birth 1 36.19
10 EB 25 M Malaria 6 0.76 LP 72.38
11 EB 21 M ROP  ~ Birth 1 78.10
12 LB* 30 F Glaucoma 7 0.77 78.10
13 LB* 43 F Sturge-Weber syndrome 8 0.81 83.81
14 LB 56 F RP 24 0.57 78.10
15 LB 47 M Glaucoma 40 0.15 74.29
16 LB 45 F Glaucoma + aniridia 17 0.62 80
17 LB 45 M Accident 17 0.62 93.33
18 LB 30 M Leber amaurosis 18 0.40 79.05
19 LB 56 F RP + glaucoma 32 0.43 LP in one eye 62.86
20 LB 51 M Accident 17 0.67 88.57
21 LB 57 M Microphthalmia 20 0.65 74.29
22 LB 27 M RP 17 0.37 56.19
23 LB 47 F Diabetic retinopathy 22 0.53 74.29
24 LB 73 M Accident 38 0.48 91.43
25 LB 38 F Glaucoma 20 0.48 87.62

BDI, blindness duration index; EB, early blind; F, female; LB, late blind; LP, light perception; M, male; ROP, retinopathy of prematurity; RP, retinitis pigmentosa; SBSOD, Santa Barbara Sense of Direction.

*Participants who were included in the EB group according to the criteria described in the text.